SHMT1 and neoplasm: Immunohistochemical analysis of 557 tumor samples revealed that SHMT1 expression was significantly elevated in PTC and poorly differentiated thyroid carcinoma, but was lowest in medullary thyroid carcinoma (Sun et al., 2016).